Kaye Biotech Inc had the following equity account balances at December 31, 2019 $ 44,100 Preferred shares, $3.10, non-cumulative, Authorized: 22,600 shares Issued and outstanding: 6,300 shares Common shares, Authorized: Unlimited Issued and outstanding: 91,500 shares Retained earnings 329,695 45,800 On February 1, 2020, 6,300 preferred shares were issued at $9.00 each. The board of directors declared and paid the annual cash dividend on the preferred shares on June 30, 2020, and a 10% common share dividend was declared and distributed on the same day when the market price per common share was $4.85. On October 1, 2020, 22,600 common shares were issued at $4.99 each. Profit earned during 2020 was $421,800 Required: Using the information provided, prepare the statement of changes in equity for the year ended December 31, 2020. (Amounts to be deducted should be indicated by a minus sign.) KAYE BIOTECH INC Statement of Changes in Equity For Year Ended December 31, 2020 Preferred Common Shares Shares Retained Earnings Total Equity Balance, January 1 0 0 Balance, December 31 5 0 $ $ ols 0